Article info
PDFA difficult case
Refractory CIDP with chronic lymphocytic leukaemia responding to chemoimmunotherapy
- Correspondence to Dr Chinar Osman, Wessex Neurological Centre, Southampton University Hospitals NHS Trust, Southampton, Southampton, UK; chinar.osman{at}uhs.nhs.uk
Citation
Refractory CIDP with chronic lymphocytic leukaemia responding to chemoimmunotherapy
Publication history
- Accepted December 14, 2020
- First published December 29, 2020.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Intravenous immunoglobulin response in treatment - naïve chronic inflammatory demyelinating polyradiculoneuropathy
- Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies
- Serum IgG levels in IV immunoglobulin treated chronic inflammatory demyelinating polyneuropathy
- Chronic inflammatory demyelinating polyneuropathy: update on diagnosis, immunopathogenesis and treatment
- Hereditary and inflammatory neuropathies: a review of reported associations, mimics and misdiagnoses
- Chronic inflammatory demyelinating polyneuropathy: decreased claudin-5 and relocated ZO-1
- Different electrophysiological profiles and treatment response in ‘ typical ’ and ‘ atypical ’ chronic inflammatory demyelinating polyneuropathy
- Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy
- Chronic inflammatory demyelinating polyradiculoneuropathy presenting as predominantly sciatic monomelic neuropathy
- Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP